QA: Neximmune Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001538210_2022_Neximmune_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001538210, Neximmune Inc

  xvar xval
0 AssetsCurrent 86,280,710
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,427,307
3 remainder_Assets 324,099
4 LiabilitiesCurrent 7,215,868
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 55,581
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,799,432
9 ResearchAndDevelopmentExpense 37,456,350
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,354,274
13 remainder_ComprehensiveNetIncome 3,012
  yvar yval
0 Assets 91,032,116
1 Liabilities 7,271,449
2 Expenses 53,255,782
3 Revenues 0
4 StockholdersEquity 83,760,667
5 NetIncome -50,901,508
6 ComprehensiveNetIncome -50,900,002
7 BaseVar 76,958,316
8 EconomicCapitalRatiobeforeLimitedLiability 2.68
9 EconomicCapitalRatio 3.47

Edgar->Model Mapping

Feature Distribution